{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Houston&page=43&state=Texas", "query": { "state": "Texas", "city": "Houston", "page": 43 }, "page_size": 10 }, "pagination": { "page": 43, "page_size": 10, "total_count": 22526, "total_pages": 2253, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Houston&page=44&state=Texas&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Houston&page=42&state=Texas&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T13:14:38.046Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07215468", "title": "HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV -1 Infection" ], "interventions": [ { "name": "TMB-365", "type": "DRUG" }, { "name": "TMB-380", "type": "DRUG" }, { "name": "Baseline ART", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "TaiMed Biologics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 88, "start_date": "2025-12-16", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-11-15T13:14:38.046Z", "location_count": 10, "location_summary": "San Francisco, California • Fort Lauderdale, Florida • Ft. Pierce, Florida + 7 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Ft. Pierce", "state": "Florida" }, { "city": "Miami Gardens", "state": "Florida" }, { "city": "Oakland Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07215468" }, { "nct_id": "NCT00042250", "title": "IUdR/BUdR Cell Cycle Labelling", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hematologic Malignancies" ], "interventions": [ { "name": "Chemotherapy for hematologic malignancy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "1992-05", "completion_date": "2002-10", "has_results": false, "last_update_posted_date": "2012-01-24", "last_synced_at": "2026-11-15T13:14:38.046Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00042250" }, { "nct_id": "NCT02126774", "title": "The Human Epilepsy Project", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Focal Epilepsy" ], "interventions": [], "intervention_types": [], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "12 Years to 60 Years" }, "enrollment_count": 488, "start_date": "2012-07", "completion_date": "2021-07-01", "has_results": false, "last_update_posted_date": "2021-07-06", "last_synced_at": "2026-11-15T13:14:38.046Z", "location_count": 26, "location_summary": "Birmingham, Alabama • San Francisco, California • Denver, Colorado + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02126774" }, { "nct_id": "NCT07604974", "title": "A Study to Assess the Safety, Tolerability and Efficacy of ION775", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertriglyceridemia", "Severe Hypertriglyceridemia" ], "interventions": [ { "name": "ION775", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ionis Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2026-05-12", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-11-02", "last_synced_at": "2026-11-15T13:14:38.046Z", "location_count": 16, "location_summary": "Lincoln, California • Aurora, Colorado • Boca Raton, Florida + 13 more", "locations": [ { "city": "Lincoln", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miramar", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07604974" }, { "nct_id": "NCT03476876", "title": "Comparative Effectiveness of Two Acellular Matrices (Dermacell vs. Integra) for Management of Deep Diabetic Foot Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Diabetic Foot Ulcer", "Deep Diabetic Foot Ulcer" ], "interventions": [ { "name": "Dermacell", "type": "COMBINATION_PRODUCT" }, { "name": "Integra", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "2018-04-02", "completion_date": "2021-04-02", "has_results": true, "last_update_posted_date": "2023-07-07", "last_synced_at": "2026-11-15T13:14:38.046Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03476876" }, { "nct_id": "NCT00225550", "title": "A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Neoplasms" ], "interventions": [ { "name": "ADH -1 (Exherin™)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Adherex Technologies, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2007-08-06", "last_synced_at": "2026-11-15T13:14:38.046Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00225550" }, { "nct_id": "NCT05219968", "title": "Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Sinusitis", "Chronic Rhinosinusitis (Diagnosis)" ], "interventions": [ { "name": "LYR-210", "type": "DRUG" }, { "name": "Sham procedure control", "type": "DRUG" }, { "name": "Background Therapy", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Lyra Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 196, "start_date": "2022-01-27", "completion_date": "2024-09-16", "has_results": true, "last_update_posted_date": "2025-05-02", "last_synced_at": "2026-11-15T13:14:38.046Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Escondido, California • La Mesa, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Escondido", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05219968" }, { "nct_id": "NCT05823974", "title": "A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "F2C22C/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2B22A/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2B22B/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2B22C/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2B22D/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2B22E/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2F22A/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2F22B/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2F22C/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2F22D/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2F22E/DL001Z", "type": "BIOLOGICAL" }, { "name": "Control 1", "type": "COMBINATION_PRODUCT" }, { "name": "F2F23D/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "F2F23A/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "F2F23B/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "Control 2", "type": "COMBINATION_PRODUCT" }, { "name": "F2F23C/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "Control 3", "type": "COMBINATION_PRODUCT" }, { "name": "F2F22F/DL001Z", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "COMBINATION_PRODUCT" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 1275, "start_date": "2023-04-27", "completion_date": "2024-12-18", "has_results": true, "last_update_posted_date": "2025-07-23", "last_synced_at": "2026-11-15T13:14:38.046Z", "location_count": 24, "location_summary": "Hialeah, Florida • Miami, Florida • Chicago, Illinois + 21 more", "locations": [ { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Valparaiso", "state": "Indiana" }, { "city": "Lenexa", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05823974" }, { "nct_id": "NCT06805825", "title": "A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gastrointestinal Stromal Tumors", "Small-cell Lung Cancer", "Adenoid Cystic Carcinoma", "Uveal Melanoma", "Neuroendocrine Tumors", "Chromophobe Renal Cell Carcinoma", "Clear Cell Renal Cell Carcinoma" ], "interventions": [ { "name": "NN3201", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novelty Nobility, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 67, "start_date": "2025-02-03", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-11-13", "last_synced_at": "2026-11-15T13:14:38.046Z", "location_count": 5, "location_summary": "Ann Arbor, Michigan • Cleveland, Ohio • Portland, Oregon + 2 more", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Portland", "state": "Oregon" }, { "city": "Houston", "state": "Texas" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06805825" }, { "nct_id": "NCT05130268", "title": "Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atrial Fibrillation" ], "interventions": [ { "name": "Dronedarone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "American Heart Association", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 339, "start_date": "2021-10-29", "completion_date": "2024-06-30", "has_results": false, "last_update_posted_date": "2025-01-28", "last_synced_at": "2026-11-15T13:14:38.046Z", "location_count": 103, "location_summary": "Fairhope, Alabama • Gilbert, Arizona • Scottsdale, Arizona + 78 more", "locations": [ { "city": "Fairhope", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05130268" } ] }